Uncategorized files
Jump to navigation
Jump to search
Showing below up to 50 results in range #7,101 to #7,150.
-
Autosomal Dominant-polycystic-kidney-disease-002.jpg 778 × 578; 40 KB
-
Autosomal Dominant-polycystic-kidney-disease-003.jpg 766 × 541; 36 KB
-
Autosomal Dominant-polycystic-kidney-disease-004.jpg 709 × 793; 53 KB
-
Autosomal Dominant-polycystic-kidney-disease-005.jpg 656 × 795; 57 KB
-
Autosomal Dominant.png 662 × 748; 136 KB
-
Autosomal Dominant Pedigree Chart.png 600 × 600; 27 KB
-
Autosomal Dominant Pedigree Chart.svg 600 × 600; 27 KB
-
Autosomal dominant.png 738 × 1,283; 163 KB
-
Autosomal dominant - en.png 1,476 × 2,567; 210 KB
-
Autosomal dominant polycystic kidney disease 101.jpg 645 × 700; 53 KB
-
Autosomal dominant polycystic kidney disease 102.jpg 553 × 700; 48 KB
-
Autosomal recessive gene.png 300 × 351; 24 KB
-
Autosplenectomy.jpg 630 × 630; 63 KB
-
Avacopan Drug Information.png 658 × 1,110; 156 KB
-
Avacopan Drug Label 180 Tablets.png 1,312 × 494; 643 KB
-
Avacopan Drug Label 30 Tablets.png 1,316 × 558; 735 KB
-
Avacopan Drug Packaging 30 Tablets.png 1,314 × 1,216; 621 KB
-
Avacopan Figure 1 Sustained Remission.png 1,324 × 1,454; 457 KB
-
Avacopan Packaging 180 Tablets.png 1,300 × 1,224; 540 KB
-
Avacopan Structure.png 618 × 436; 77 KB
-
Avacopan Structure 2.png 686 × 578; 37 KB
-
Avacopan Table 1 Adverse Reactions.png 1,272 × 1,244; 191 KB
-
Avacopan Table 2 Pharmacokinetics with M1.png 1,290 × 936; 174 KB
-
Avacopan Table 3 Pharmacokinetcis Changes.png 1,288 × 758; 147 KB
-
Avacopan Table 4 Sustained Remission.png 1,282 × 824; 175 KB
-
Avalglucosidase alfa-ngpt Drug Packaging.png 1,334 × 1,410; 713 KB
-
Avalglucosidase alfa-ngpt Figure 1 FVC.png 1,288 × 842; 241 KB
-
Avalglucosidase alfa-ngpt Figure 2 Walking.png 1,274 × 816; 238 KB
-
Avalglucosidase alfa-ngpt Packaging Label.png 656 × 1,484; 230 KB
-
Avalglucosidase alfa-ngpt Packaging Label 2.png 646 × 156; 25 KB
-
Avalglucosidase alfa-ngpt Table 1 Infusion Rate.png 1,240 × 902; 134 KB
-
Avalglucosidase alfa-ngpt Table 2 Adverse Reactions.png 1,204 × 1,162; 183 KB
-
Avalglucosidase alfa-ngpt Table 3 Antibodies.png 612 × 856; 141 KB
-
Avalglucosidase alfa-ngpt Table 4 FVC.png 1,202 × 1,024; 208 KB
-
Avalglucosidase alfa-ngpt Table 5 Walking.png 1,216 × 970; 193 KB
-
Avanafil.png 800 × 547; 20 KB
-
Avanafil ball-and-stick.png 1,024 × 635; 154 KB
-
Avanafil fig1.png 662 × 292; 56 KB
-
Avanafil fig2.png 674 × 388; 94 KB
-
Avanafil fig3.png 658 × 386; 90 KB
-
Avanafil fig4.png 667 × 405; 96 KB
-
Avanafil image.jpg 816 × 204; 91 KB
-
Avanafil image1.jpg 811 × 198; 94 KB
-
Avanafil image2.jpg 997 × 1,022; 367 KB
-
Avanafil ingredients and appearance.png 633 × 3,807; 344 KB
-
Avanafil patient information.png 633 × 3,399; 525 KB
-
Avanafil structure.png 300 × 211; 23 KB
-
Avanafil supply.png 472 × 182; 11 KB
-
Avanafil table5.png 380 × 306; 28 KB
-
Avanafil table6.png 369 × 287; 23 KB
